These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22014548)

  • 1. Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.
    Wang Y; Hess TN; Jones V; Zhou JZ; McNeil MR; Andrew McCammon J
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7064-7. PubMed ID: 22014548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure prediction, molecular simulations of RmlD from Mycobacterium tuberculosis, and interaction studies of Rhodanine derivatives for anti-tuberculosis activity.
    N H; P SR; Sura M; Daddam JR
    J Mol Model; 2021 Feb; 27(3):75. PubMed ID: 33547544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in
    Ravichandran R; Ridzwan NFW; Mohamad SB
    J Biomol Struct Dyn; 2022 Jul; 40(11):5069-5078. PubMed ID: 33382017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose.
    Ma Y; Stern RJ; Scherman MS; Vissa VD; Yan W; Jones VC; Zhang F; Franzblau SG; Lewis WH; McNeil MR
    Antimicrob Agents Chemother; 2001 May; 45(5):1407-16. PubMed ID: 11302803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation on a theme of SDR. dTDP-6-deoxy-L- lyxo-4-hexulose reductase (RmlD) shows a new Mg2+-dependent dimerization mode.
    Blankenfeldt W; Kerr ID; Giraud MF; McMiken HJ; Leonard G; Whitfield C; Messner P; Graninger M; Naismith JH
    Structure; 2002 Jun; 10(6):773-86. PubMed ID: 12057193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression, purification, crystallization and preliminary structural study of dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD), the fourth enzyme of the dTDP-L-rhamnose synthesis pathway, from Salmonella enterica serovar Typhimurium.
    Giraud MF; McMiken HJ; Leonard GA; Messner P; Whitfield C; Naismith JH
    Acta Crystallogr D Biol Crystallogr; 1999 Dec; 55(Pt 12):2043-6. PubMed ID: 10666586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 96-well microtiter plate assay for high-throughput screening of Mycobacterium tuberculosis dTDP-d-glucose 4,6-dehydratase inhibitors.
    Shi X; Sha S; Liu L; Li X; Ma Y
    Anal Biochem; 2016 Apr; 498():53-8. PubMed ID: 26778528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine diphosphate-6-deoxy-L-lyxo-4-hexulose reductase synthesizing dTDP-6-deoxy-L-talose from Actinobacillus actinomycetemcomitans.
    Nakano Y; Suzuki N; Yoshida Y; Nezu T; Yamashita Y; Koga T
    J Biol Chem; 2000 Mar; 275(10):6806-12. PubMed ID: 10702238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure based virtual screening and discovery of novel inhibitors against FabD protein of
    Sundararajan S; Karunakaran K; Muniyan R
    J Biomol Struct Dyn; 2024 Aug; 42(12):6280-6291. PubMed ID: 37424186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase.
    Luciani R; Saxena P; Surade S; Santucci M; Venturelli A; Borsari C; Marverti G; Ponterini G; Ferrari S; Blundell TL; Costi MP
    J Med Chem; 2016 Oct; 59(19):9269-9275. PubMed ID: 27589670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
    Shelke RU; Degani MS; Raju A; Ray MK; Rajan MG
    Arch Pharm (Weinheim); 2016 Aug; 349(8):602-13. PubMed ID: 27320965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
    He X; Alian A; Ortiz de Montellano PR
    Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomolar inhibitors of Mycobacterium tuberculosis glutamine synthetase 1: synthesis, biological evaluation and X-ray crystallographic studies.
    Couturier C; Silve S; Morales R; Pessegue B; Llopart S; Nair A; Bauer A; Scheiper B; Pöverlein C; Ganzhorn A; Lagrange S; Bacqué E
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1455-9. PubMed ID: 25770781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dTDP-4-dehydrorhamnose 3,5-epimerase and dTDP-4-dehydrorhamnose reductase, required for dTDP-L-rhamnose biosynthesis in Salmonella enterica serovar Typhimurium LT2.
    Graninger M; Nidetzky B; Heinrichs DE; Whitfield C; Messner P
    J Biol Chem; 1999 Aug; 274(35):25069-77. PubMed ID: 10455186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.